4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 90 | 15 | 14 | 1 | 3 |
| Gross Profit | 90 | 15 | 14 | 1 | 3 |
| Operating Expenses | 61,275 | 59,471 | 53,635 | 56,118 | 51,135 |
| Operating Income | -61,185 | -59,456 | -53,621 | -56,117 | -51,132 |
| Other Income | 4,309 | 4,798 | 5,649 | 6,446 | 7,289 |
| Pre-tax Income | -56,876 | -54,658 | -47,972 | -49,671 | -43,843 |
| Net Income Continuous | -56,876 | -54,658 | -47,972 | -49,671 | -43,843 |
| Net Income | $-56,876 | $-54,658 | $-47,972 | $-49,671 | $-43,843 |
| EPS Basic Total Ops | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 |
| EPS Basic Continuous Ops | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 |
| EPS Diluted Total Ops | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 |
| EPS Diluted Continuous Ops | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 |
| EPS Diluted Before Non-Recurring Items | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 |
| EBITDA(a) | $-61,078 | $-59,456 | $-53,837 | $-56,871 | $-52,182 |